BH 4 levels and expression of the CTP cyclohydrolase I in the setting of eNOS uncoupling
Marino C, Pagano I, Castaldo G, Grimaldi M, DElia M, Santoro A, Conte A, Molettieri P, Parisella C, Buonocore M et al
Additionally, while a plateau in weight loss was observed in the placebo group at week 18, weight-loss with cagrilintide continued throughout the 26 weeks
Premature ovarian insufficiency (POI), previously referred to as premature ovarian failure or premature menopause, affecting approximately 1% of women under 40, is not only a reproductive crisis but a sentinel event with profound long-term health consequences, ranging from cardiovascular and skeletal complications to cognitive decline (Roeters van Lennep et al., 2016